Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Issue title: The Third Conference of the International CoQ10 Association
Article type: Research Article
Authors: Rosenfeldt, Franklin; | Hilton, Deborah | Pepe, Salvatore | Krum, Henry;
Affiliations: Cardiac Surgical Research Unit, Alfred Hospital and Baker Institute, Melbourne, Victoria, Australia | Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia | Department of Clinical Pharmacology, Alfred Hospital, Melbourne, Victoria, Australia
Note: [] Address for correspondence: Assoc. Prof. Franklin Rosenfeldt, Department of Cardiothoracic Surgery, The Alfred Hospital, PO Box 315, Prahran, Victoria 3181, Australia. Tel.: +61 3 9276 3684; Fax: +61 3 9276 2317; E-mail: f.rosenfeldt@alfred.org.au
Abstract: Coenzyme Q_{10} in physical exercise. We identified eleven studies in which CoQ_{10} was tested for an effect on exercise capacity, six showed a modest improvement in exercise capacity with CoQ_{10} supplementation but five showed no effect. CoQ_{10} in hypertension. We identified eight published trials of CoQ_{10} in hypertension. Altogether in the eight studies the mean decrease in systolic blood pressure was 16 mm Hg and in diastolic blood pressure, 10 mm Hg. Being devoid of significant side effects CoQ_{10} may have a role as an adjunct or alternative to conventional agents in the treatment of hypertension. CoQ_{10} in heart failure. We performed a randomised double blind placebo-controlled pilot trial of CoQ_{10} therapy in 35 patients with heart failure. Over 3 months, in the CoQ_{10} patients but not in the placebo patients there were significant improvements in symptom class and a trend towards improvements in exercise time. Meta-analysis of randomised trials of coenzyme Q_{10} in heart failure. In nine randomised trials of CoQ_{10} in heart failure published up to 2003 there were non-significant trends towards increased ejection fraction and reduced mortality. There were insufficient numbers of patients for meaningful results. To make more definitive conclusions regarding the effect of CoQ_{10} in cardiac failure we recommend a prospective, randomised trial with 200–300 patients per study group. Further trials of CoQ_{10} in physical exercise and in hypertension are recommended.
Keywords: coenzyme Q[TeX:] _{10}, exercise, hypertension, heart failure
Journal: BioFactors, vol. 18, no. 1-4, pp. 91-100, 2003
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl